ISI NucMed 2022 – Du 3 au 6 juin 2023, Nantes
During four days, 20 participants will deepen their knowledge in some of the main research areas in nuclear medicine, with a focus on alpha emitting radionuclides (astatine-211 in particular). [...]
By SIRIC ILIAD
Posted A look back at … the Cancer and Work Meeting
The conference “Living and working with cancer” was held on Wednesday 23 November at the Cité des sciences et de l’industrie in Paris. This conference brought together more than [...]
REWORK: A toolbox to facilitate the return to work
After 5 years of research, the REWORK programme of SIRIC ILIAD is about to release a toolbox for patients with breast cancer, which includes materials to help them return to work. An achievement [...]
SIRIC ILIAD is proud to count Philippe Moreau as one of the most influential researchers in the world 2022
The annual Clarivate – Highly Cited Researchers ranking has, for the seventh consecutive year, recognised Professor Philippe Moreau, Director of SIRIC ILIAD, as a Highly Cited Researcher in [...]
Modeling tumor development and progression: From PDXs to cancer organoids | A colloquium sponsored by SIRIC ILIAD
On October 18th, the French PDX network and the Organoids research group organised, with the support of the SIRIC ILIAD and the CRCI²NA, a hybrid colloquium : Modeling tumor development and [...]
New AF3M newsletter: AIDES & RIGHTS
As part of the National Multiple Myeloma Information Day (JNM 2022) of the AF3M (Association Française des Malades du Myélome Multiple), the association has released a new information bulletin [...]
A look back at the National Multiple Myeloma Information Day – JNM 2022 | AF3M
On Saturday 15 October, SIRIC ILIAD was present at the National Information Day on Multiple Myeloma (JNM 2022) of the AF3M (French Association of Multiple Myeloma Patients) in Nantes. For the [...]
Breast cancers: acting on cells in the tumour environment to treat the cancer?
What if acting on the cells surrounding the tumour could improve the effectiveness of treatments? On 14 September 2022, a team from the SIRIC ILIAD specialising in breast cancer published a [...]
By SIRIC ILIAD
In Announcements, Patients and the general public, Programme 1 - ThARGET, Programme 2 - PISTER, Programme 3 - ReWork-QoL
Posted SIRIC ILIAD shares its research progress with its partners | SIRIC Review 2018-2022
The SIRIC ILIAD Partners Committee met on Monday 17 October 2022 to present the results of the 5 years of labelling. A week ago, the fifth meeting of the SIRIC ILIAD Partners Committee took place [...]
General Public Conference « Living and working with cancer » INCa – 23 Nov 2022
The French National Cancer Institute is organising a day of debate and exchange for the general public on the issue of maintaining and returning to work for people affected by cancer: [...]